Geode Capital Management’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.32M | Sell |
578,081
-8,435
| -1% | -$33.9K | ﹤0.01% | 3091 |
|
2025
Q1 | $2.04M | Buy |
586,516
+19,133
| +3% | +$66.4K | ﹤0.01% | 3021 |
|
2024
Q4 | $3.73M | Buy |
567,383
+14,136
| +3% | +$93K | ﹤0.01% | 2878 |
|
2024
Q3 | $5M | Buy |
553,247
+256,635
| +87% | +$2.32M | ﹤0.01% | 2759 |
|
2024
Q2 | $4.76M | Buy |
296,612
+98,813
| +50% | +$1.59M | ﹤0.01% | 2754 |
|
2024
Q1 | $3.1M | Buy |
197,799
+97,378
| +97% | +$1.53M | ﹤0.01% | 2934 |
|
2023
Q4 | $1.35M | Buy |
+100,421
| New | +$1.35M | ﹤0.01% | 3228 |
|